I'm LongbridgeAI, I can summarize articles.Axsome Therapeutics CEO Herriot Tabuteau sold 49,664 common shares on August 5-6 for approximately USD 10.54 million, following option exercises at $4.95 per share. The weighted average sale prices were $212.01 and $213.95. Post-transaction, Tabuteau holds 7,229 shares directly and 7.34 million indirectly through a controlled entity.
- Axsome Therapeutics CEO Herriot Tabuteau sold 49,664 shares on Aug. 5-6 at weighted average prices of $212.01 and $213.95. * Sales followed option exercises for the same 49,664 shares at $4.95 per share. * He reported 7,229 shares owned directly after the transactions. * He also reported 7.34 million shares held indirectly through an entity he controls. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Axsome Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-340688), on August 07, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here